在急性髓性白血病中进行血造干细胞移植后的维持疗法
Martina Canichella1, Matteo Molica2, Carla Mazzone1
1Hematology, St. Eugenio Hospital, ASL Roma2, 00144 Rome, Italy.
Current oncology (Toronto, Ont.)
|October 25, 2024
概括
造血干细胞移植 (HSCT) 后的维持疗法可以减少高风险急性髓性白血病的复发. 虽然有希望,但由于前性试验不足,缺乏标准化指导方针.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 干细胞移植 干细胞移植
背景情况:
- 高风险的急性髓性白血病 (AML) 预后不佳.
- 造血干细胞移植 (HSCT) 是符合条件的AML患者唯一的治疗选择.
- 在HSCT后复发显著降低了生存机会.
研究的目的:
- 审查旨在减少AML在HSCT后复发的维持策略.
- 突出各种维护方法的有效性.
- 确定当前的研究缺口和未来的方向.
主要方法:
- 对AML的临床试验和HSCT后维持策略研究的文献综述.
- 分析报告的疗效和与不同维持治疗相关的结果.
- 综合现有证据,并确定需要进一步调查的领域.
主要成果:
- 临床试验数据表明,在AML中,HSCT后的维护策略对AML有好处.
- 已经研究了几种维护方法,显示了不同程度的有效性.
- 有证据表明,有可能降低复发率,改善生存结果.
结论:
- 维护疗法是一种有希望的策略,可以改善高风险AML的HSCT后的结果.
- 由于缺乏明确的前性临床试验,目前无法提供标准化指南.
- 需要进一步的研究,以建立最佳的维护协议,并解决剩余的临床问题.
更多相关视频
03:40Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
Published on: December 8, 2023
910
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.2K
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Bone Marrow Sampling and Transplants
304
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
304
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
